Assay Report Card

Basic Information

ID: ALA3721014

Type: Functional

Description: Antagonist activity against human lung GPR34 expressed in CHO cells co-expressing Galpha116 assessed as inhibition of lysophosphatidyl serine-induced increase in intracellular calcium level pre-incubated before lysophosphatidyl serine addition and measured after 180 secs by Fluo 3-AM dye based fluorescent assay

Organism: Homo sapiens

Cell type: CHO

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
459.934.194.19
530.006.016.01
518.035.935.93
538.045.835.83
555.066.696.69
512.015.875.87
540.027.077.07
546.047.137.13
543.986.106.10
529.986.666.66
497.986.086.08
530.006.016.01
530.006.016.01
536.026.076.07
527.025.455.45
527.025.455.45
542.067.237.23
542.067.237.23
583.687.507.50
560.057.377.37
531.636.316.31
540.027.077.07
525.996.766.76
517.595.745.74
556.086.896.89
553.015.855.85
541.006.346.34
525.996.766.76
541.006.346.34
543.986.906.90
525.997.207.20
543.986.906.90
540.027.077.07
525.006.496.49
539.036.506.50
525.006.496.49
539.036.506.50
525.995.895.89
543.986.036.03
512.016.416.41
512.016.416.41
525.995.665.66
532.025.725.72
526.985.055.05
525.015.695.69
543.985.805.80
543.985.805.80
525.995.665.66
525.995.665.66
543.985.805.80
540.026.006.00
550.025.465.46
551.014.864.86
526.985.055.05
509.545.155.15
592.665.805.80
603.104.654.65
525.995.665.66
525.995.665.66
540.025.975.97
540.025.975.97
556.025.575.57
553.025.565.56
560.446.316.31
552.036.166.16
531.615.825.82
549.635.795.79
546.004.864.86
543.985.805.80
543.985.805.80
540.026.006.00
538.635.035.03
525.995.665.66
519.605.125.12
540.025.975.97
533.564.884.88
560.446.316.31
551.005.535.53
554.056.226.22